Trial Profile
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Corticosteroids; Dexamethasone; Prednisone
- Indications Brain metastases
- Focus Therapeutic Use
- 15 Jul 2021 Status changed from active, no longer recruiting to discontinued.
- 15 Jul 2021 Status changed from active, no longer recruiting to discontinued.
- 27 Nov 2018 Status changed from recruiting to active, no longer recruiting.